Sanofi
Ferritin Proteins

Last updated:

Abstract:

Ferritin proteins comprising a mutation replacing a surface-exposed amino acid with a cysteine, an N- or C-terminal linker comprising a cysteine, and/or one or more immune-stimulatory moieties linked to the ferritin protein via a surface-exposed amino acid are disclosed. The ferritin proteins can further comprise a non-ferritin polypeptide and be antigenic, e.g., for use in eliciting antibodies against the non-ferritin polypeptide.

Status:
Application
Type:

Utility

Filling date:

1 Oct 2020

Issue date:

22 Apr 2021